• Share
  • Email
  • Embed
  • Like
  • Save
  • Private Content
TLR ligand functionalized nanocarriers to enhance immunogenicity of vaccines
 

TLR ligand functionalized nanocarriers to enhance immunogenicity of vaccines

on

  • 540 views

VHIR Seminar led by Gerrit Borchard, Section of Pharmaceutical Sciences University of Geneva, University of Lausanne Biopharmaceutical Sciences Geneva Switzerland. ...

VHIR Seminar led by Gerrit Borchard, Section of Pharmaceutical Sciences University of Geneva, University of Lausanne Biopharmaceutical Sciences Geneva Switzerland.

Abstract: In order to enhance the efficacy of vaccines, antigen and adjuvants are combined in particulate carrier systems resembling pathogens in size, shape and surface properties. These novelnano- and microcarriervaccines strategies, using DNA or subunit vaccines as antigens and specific ligands of receptors of the innate immune system,offer several advantages, such as enhanced immune recognition, direction of immune response bias, and enhancement of vaccine stability. We are focusing on eliciting protective immune responses against M. tuberculosis, a pathogen transmitted through inhalation, bydeveloping vaccine delivery systems composed of different materialsand administered by the mucosal route.

Statistics

Views

Total Views
540
Views on SlideShare
512
Embed Views
28

Actions

Likes
0
Downloads
2
Comments
0

1 Embed 28

http://www.scoop.it 28

Accessibility

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

    TLR ligand functionalized nanocarriers to enhance immunogenicity of vaccines TLR ligand functionalized nanocarriers to enhance immunogenicity of vaccines Presentation Transcript